CN108524682A - 一种儿童过敏性鼻炎膏及其制备方法 - Google Patents
一种儿童过敏性鼻炎膏及其制备方法 Download PDFInfo
- Publication number
- CN108524682A CN108524682A CN201810760818.1A CN201810760818A CN108524682A CN 108524682 A CN108524682 A CN 108524682A CN 201810760818 A CN201810760818 A CN 201810760818A CN 108524682 A CN108524682 A CN 108524682A
- Authority
- CN
- China
- Prior art keywords
- parts
- mixture
- children
- allergic rhinitis
- vitamin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 206010039085 Rhinitis allergic Diseases 0.000 title claims abstract description 56
- 201000010105 allergic rhinitis Diseases 0.000 title claims abstract description 56
- 239000006071 cream Substances 0.000 title claims abstract description 46
- 238000002360 preparation method Methods 0.000 title claims abstract description 23
- 239000000203 mixture Substances 0.000 claims abstract description 117
- 239000000463 material Substances 0.000 claims abstract description 30
- 150000001413 amino acids Chemical class 0.000 claims abstract description 18
- 240000005528 Arctium lappa Species 0.000 claims abstract description 17
- 229940099259 vaseline Drugs 0.000 claims abstract description 17
- 235000003130 Arctium lappa Nutrition 0.000 claims abstract description 16
- 241000758794 Asarum Species 0.000 claims abstract description 16
- 244000246386 Mentha pulegium Species 0.000 claims abstract description 16
- 235000016257 Mentha pulegium Nutrition 0.000 claims abstract description 16
- 235000004357 Mentha x piperita Nutrition 0.000 claims abstract description 16
- 235000001050 hortel pimenta Nutrition 0.000 claims abstract description 16
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 15
- 241000628997 Flos Species 0.000 claims abstract description 15
- 229940088594 vitamin Drugs 0.000 claims abstract description 15
- 229930003231 vitamin Natural products 0.000 claims abstract description 15
- 235000013343 vitamin Nutrition 0.000 claims abstract description 15
- 239000011782 vitamin Substances 0.000 claims abstract description 15
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 15
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims abstract description 14
- 235000006226 Areca catechu Nutrition 0.000 claims abstract description 14
- 235000005206 Hibiscus Nutrition 0.000 claims abstract description 14
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 claims abstract description 14
- 244000048199 Hibiscus mutabilis Species 0.000 claims abstract description 14
- 235000003973 Hibiscus mutabilis Nutrition 0.000 claims abstract description 14
- 244000284380 Hibiscus rosa sinensis Species 0.000 claims abstract description 14
- 239000009636 Huang Qi Substances 0.000 claims abstract description 14
- 235000008291 Poterium sanguisorba Nutrition 0.000 claims abstract description 14
- 235000008282 Sanguisorba officinalis Nutrition 0.000 claims abstract description 14
- 241001251949 Xanthium sibiricum Species 0.000 claims abstract description 14
- BLUAFEHZUWYNDE-NNWCWBAJSA-N artemisinin Chemical compound C([C@](OO1)(C)O2)C[C@H]3[C@H](C)CC[C@@H]4[C@@]31[C@@H]2OC(=O)[C@@H]4C BLUAFEHZUWYNDE-NNWCWBAJSA-N 0.000 claims abstract description 14
- 229930101531 artemisinin Natural products 0.000 claims abstract description 14
- 229930183339 qinghaosu Natural products 0.000 claims abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 14
- 240000004064 Poterium sanguisorba Species 0.000 claims abstract description 13
- 240000008488 Thlaspi arvense Species 0.000 claims abstract description 12
- 235000008214 Thlaspi arvense Nutrition 0.000 claims abstract description 12
- 241000005787 Cistanche Species 0.000 claims abstract description 11
- 244000235603 Acacia catechu Species 0.000 claims abstract description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 29
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 26
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 22
- 235000011837 pasties Nutrition 0.000 claims description 18
- 229940024606 amino acid Drugs 0.000 claims description 17
- 235000001014 amino acid Nutrition 0.000 claims description 17
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 14
- 239000004472 Lysine Substances 0.000 claims description 14
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 14
- 229930003427 Vitamin E Natural products 0.000 claims description 14
- 238000000605 extraction Methods 0.000 claims description 14
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 14
- 235000019165 vitamin E Nutrition 0.000 claims description 14
- 239000011709 vitamin E Substances 0.000 claims description 14
- 229940046009 vitamin E Drugs 0.000 claims description 14
- ZKLPARSLTMPFCP-OAQYLSRUSA-N 2-[2-[4-[(R)-(4-chlorophenyl)-phenylmethyl]-1-piperazinyl]ethoxy]acetic acid Chemical compound C1CN(CCOCC(=O)O)CCN1[C@@H](C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZKLPARSLTMPFCP-OAQYLSRUSA-N 0.000 claims description 13
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 13
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 13
- 229930003268 Vitamin C Natural products 0.000 claims description 13
- WOLHOYHSEKDWQH-UHFFFAOYSA-N amantadine hydrochloride Chemical compound [Cl-].C1C(C2)CC3CC2CC1([NH3+])C3 WOLHOYHSEKDWQH-UHFFFAOYSA-N 0.000 claims description 13
- 239000000284 extract Substances 0.000 claims description 13
- 235000013922 glutamic acid Nutrition 0.000 claims description 13
- 239000004220 glutamic acid Substances 0.000 claims description 13
- 229960001508 levocetirizine Drugs 0.000 claims description 13
- 235000019154 vitamin C Nutrition 0.000 claims description 13
- 239000011718 vitamin C Substances 0.000 claims description 13
- 229960001280 amantadine hydrochloride Drugs 0.000 claims description 12
- 229960002885 histidine Drugs 0.000 claims description 11
- 229960005404 sulfamethoxazole Drugs 0.000 claims description 10
- JLKIGFTWXXRPMT-UHFFFAOYSA-N sulphamethoxazole Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 JLKIGFTWXXRPMT-UHFFFAOYSA-N 0.000 claims description 10
- 238000000227 grinding Methods 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 6
- 229910052751 metal Inorganic materials 0.000 claims description 6
- 239000002184 metal Substances 0.000 claims description 6
- 150000002739 metals Chemical class 0.000 claims description 6
- 235000015927 pasta Nutrition 0.000 claims description 6
- 238000003815 supercritical carbon dioxide extraction Methods 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 4
- 238000000926 separation method Methods 0.000 claims description 4
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 3
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 3
- 235000013372 meat Nutrition 0.000 claims description 3
- 230000010355 oscillation Effects 0.000 claims description 3
- 235000004400 serine Nutrition 0.000 claims description 3
- 230000003068 static effect Effects 0.000 claims description 3
- 239000001569 carbon dioxide Substances 0.000 claims description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 2
- 239000002674 ointment Substances 0.000 claims description 2
- 206010039083 rhinitis Diseases 0.000 claims description 2
- 206010002198 Anaphylactic reaction Diseases 0.000 claims 1
- 230000036783 anaphylactic response Effects 0.000 claims 1
- 208000003455 anaphylaxis Diseases 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 23
- 230000003266 anti-allergic effect Effects 0.000 abstract description 4
- 239000003814 drug Substances 0.000 description 18
- 244000080767 Areca catechu Species 0.000 description 10
- 206010062717 Increased upper airway secretion Diseases 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 208000026435 phlegm Diseases 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 241000700605 Viruses Species 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 5
- 241000411851 herbal medicine Species 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 3
- 244000025254 Cannabis sativa Species 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 210000001331 nose Anatomy 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- CUMCMYMKECWGHO-UHFFFAOYSA-N 3-methyl-1,2-oxazole Chemical compound CC=1C=CON=1 CUMCMYMKECWGHO-UHFFFAOYSA-N 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 239000005864 Sulphur Substances 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 239000013566 allergen Substances 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 210000003928 nasal cavity Anatomy 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 238000000554 physical therapy Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 235000015067 sauces Nutrition 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- NQWVSMVXKMHKTF-JKSUJKDBSA-N (-)-Arctigenin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O)=CC=2)C(=O)OC1 NQWVSMVXKMHKTF-JKSUJKDBSA-N 0.000 description 1
- WHTVZRBIWZFKQO-AWEZNQCLSA-N (S)-chloroquine Chemical compound ClC1=CC=C2C(N[C@@H](C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-AWEZNQCLSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 208000028185 Angioedema Diseases 0.000 description 1
- YYGRXNOXOVZIKE-UHFFFAOYSA-N Arctigenin Natural products COC1CCC(CC2COC(=O)C2CC3CCC(O)C(C3)OC)CC1OC YYGRXNOXOVZIKE-UHFFFAOYSA-N 0.000 description 1
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 description 1
- 241000758795 Aristolochiaceae Species 0.000 description 1
- 240000000011 Artemisia annua Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241001164374 Calyx Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 241000790917 Dioxys <bee> Species 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000533849 Gleditsia Species 0.000 description 1
- 241000931143 Gleditsia sinensis Species 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- OIFFJDGSLVHPCW-UHFFFAOYSA-N Guayarol Natural products COc1ccc(CC2C(Cc3ccc(O)c(O)c3)COC2=O)cc1OC OIFFJDGSLVHPCW-UHFFFAOYSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 244000130592 Hibiscus syriacus Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 206010022678 Intestinal infections Diseases 0.000 description 1
- NQWVSMVXKMHKTF-UHFFFAOYSA-N L-Arctigenin Natural products C1=C(OC)C(OC)=CC=C1CC1C(CC=2C=C(OC)C(O)=CC=2)C(=O)OC1 NQWVSMVXKMHKTF-UHFFFAOYSA-N 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 241000218394 Magnolia liliiflora Species 0.000 description 1
- 241000218377 Magnoliaceae Species 0.000 description 1
- 241000218922 Magnoliophyta Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 206010029164 Nephrotic syndrome Diseases 0.000 description 1
- 208000025047 Non-histaminic angioedema Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 241001529246 Platymiscium Species 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000581682 Sanguisorba Species 0.000 description 1
- 244000173853 Sanguisorba officinalis Species 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- HATRDXDCPOXQJX-UHFFFAOYSA-N Thapsigargin Natural products CCCCCCCC(=O)OC1C(OC(O)C(=C/C)C)C(=C2C3OC(=O)C(C)(O)C3(O)C(CC(C)(OC(=O)C)C12)OC(=O)CCC)C HATRDXDCPOXQJX-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 206010044684 Trismus Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 241000256856 Vespidae Species 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- UPWLURAENVJIJL-UHFFFAOYSA-N adamantane;hydrochloride Chemical compound Cl.C1C(C2)CC3CC1CC2C3 UPWLURAENVJIJL-UHFFFAOYSA-N 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229960003805 amantadine Drugs 0.000 description 1
- DKNWSYNQZKUICI-UHFFFAOYSA-N amantadine Chemical compound C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- BPYGTFFYYOWDBC-LOVSFRALSA-N arctiin Natural products COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc3ccc(O[C@@H]4O[C@H](C)[C@@H](O)[C@H](O)[C@H]4O)c(OC)c3)cc1OC BPYGTFFYYOWDBC-LOVSFRALSA-N 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 229960003677 chloroquine Drugs 0.000 description 1
- WHTVZRBIWZFKQO-UHFFFAOYSA-N chloroquine Natural products ClC1=CC=C2C(NC(C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-UHFFFAOYSA-N 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 208000004921 cutaneous lupus erythematosus Diseases 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 208000006278 hypochromic anemia Diseases 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 1
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 1
- 239000003350 kerosene Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- NWFYESYCEQICQP-UHFFFAOYSA-N methylmatairesinol Natural products C1=C(OC)C(OC)=CC=C1CC1C(=O)OCC1CC1=CC=C(O)C(OC)=C1 NWFYESYCEQICQP-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000004379 myopia Effects 0.000 description 1
- 208000001491 myopia Diseases 0.000 description 1
- 208000009928 nephrosis Diseases 0.000 description 1
- 231100001027 nephrosis Toxicity 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000004126 nerve fiber Anatomy 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 238000004382 potting Methods 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- 239000002464 receptor antagonist Substances 0.000 description 1
- 229940044551 receptor antagonist Drugs 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- 229930009674 sesquiterpene lactone Natural products 0.000 description 1
- 150000002107 sesquiterpene lactone derivatives Chemical class 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 229960000468 sulfalene Drugs 0.000 description 1
- KXRZBTAEDBELFD-UHFFFAOYSA-N sulfamethopyrazine Chemical compound COC1=NC=CN=C1NS(=O)(=O)C1=CC=C(N)C=C1 KXRZBTAEDBELFD-UHFFFAOYSA-N 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000002522 swelling effect Effects 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 125000002640 tocopherol group Chemical group 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000005526 vasoconstrictor agent Substances 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/84—Valerianaceae (Valerian family), e.g. valerian
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/268—Asarum (wild ginger)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/483—Gleditsia (locust)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/64—Orobanchaceae (Broom-rape family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/739—Sanguisorba (burnet)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Otolaryngology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Insects & Arthropods (AREA)
- Immunology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种儿童过敏性鼻炎膏及其制备方法,该儿童过敏性鼻炎膏由以下质量份数的原料制成:辛夷花40‑80份、苍耳子30‑50份、路路通10‑20份、芙蓉叶5‑15份、凡士林20‑40份、艾叶8‑10份、金银花10‑30份、薄荷2‑4份、甘草3‑8份、猪牙皂20‑60份、儿茶4‑12份、露蜂房10‑30份、细辛15‑45份、地榆1‑3份、防风3‑5份、白术1‑3份、青蒿素0.1‑1份、败酱草10‑30份、肉苁蓉2‑4份、牛蒡子1‑5 份、黄芪15‑25份、维生素组合物0.02‑2份、氨基酸组合物0.4‑4份和辅料0.3‑3份。有益效果:利于儿童的使用,具有明显的抗过敏和消炎作用。
Description
技术领域
本发明涉及药物制备技术领域,具体来说,涉及一种儿童过敏性鼻炎膏及其制备方法。
背景技术
过敏性鼻炎,又称为鼻敏感,是一种成因很复杂的上呼吸道疾病。过敏性鼻炎的治疗包括避免接触变应原、药物治疗、免疫治疗、外科手术治疗及物理治疗五类,避免接触致敏的变应原是治疗的基础,但往往很难做到,而免疫治疗疗程长,外科手术治疗及物理治疗仅可减轻症状及不良反应,因此近些年倾向于以药物治疗为主,目前过敏性鼻炎的西医治疗主要是在去除接触粉尘、螨虫等外界致敏原的基础上,采用组胺HI受体拮抗剂,交感神经胺血管收缩剂和皮质类固醇等治疗方法,西药虽然能有效地控制过敏性鼻炎的症状,但根治困难,经常复发,且有严重的毒副作用。
针对相关技术中的问题,目前尚未提出有效的解决方案。
发明内容
针对相关技术中的问题,本发明提出一种儿童过敏性鼻炎膏及其制备方法,以克服现有相关技术所存在的上述技术问题。
本发明的技术方案是这样实现的:
根据本发明的一个方面,提供了一种儿童过敏性鼻炎膏。
该儿童过敏性鼻炎膏由以下质量份数的原料制成:
辛夷花40-80份、苍耳子30-50份、路路通10-20份、芙蓉叶5-15份、凡士林20-40份、艾叶8-10份、金银花10-30份、薄荷2-4份、甘草3-8份、猪牙皂20-60份、儿茶4-12份、露蜂房10-30份、细辛15-45份、地榆1-3份、防风3-5份、白术1-3份、青蒿素0.1-1份、败酱草10-30份、肉苁蓉2-4份、牛蒡子1-5 份、黄芪15-25份、维生素组合物0.02-2份、氨基酸组合物0.4-4份和辅料0.3-3份。
进一步的,所述维生素组合物包括以下原料组份:维生素E为0.01-1份和维生素C为0.01-1份。
进一步的,所述氨基酸组合物包括以下原料组份:丝氨酸为0.1-1份、谷氨酸为0.1-1份、L-组氨酸为0.1-1份和赖氨酸为0.1-1份。
进一步的,所述辅料包括以下原料组份:盐酸左西替利嗪为0.1-1份、盐酸金刚烷胺为0.1-1份和磺胺甲基异恶唑为0.1-1份。
根据本发明的另一方面,提供了一种儿童过敏性鼻炎膏的制备方法。
该儿童过敏性鼻炎膏的制备,包括以下步骤:
根据上述质量份数,称取所述儿童过敏性鼻炎膏所需各原料;
将称取好的辛夷花、苍耳子、路路通、芙蓉叶、艾叶、金银花、薄荷、甘草、猪牙皂、儿茶、露蜂房、细辛、地榆、防风、白术、青蒿素、败酱草、肉苁蓉、牛蒡子和黄芪依次进行清洗干净,晾干,将晾干后的后进行烘干、粉碎,并进行混合,形成混合物一;
通过预先设置的研磨机对所述混合物一进行研磨,促使所述混合物一的状态为粉状混合物二;
通过预先设置的金属分离器,对研磨后的混合物二进行筛选,形成混合物三;
将上述混合物三投入预先准备好的超临界二氧化碳流体萃取釜中进行萃取,制得萃取液;
将称取好的盐酸左西替利嗪、盐酸金刚烷胺和磺胺甲基异恶唑进行混合并研磨,形成混合物四;
将称取好的维生素E、维生素C、丝氨酸、谷氨酸、L-组氨酸、赖氨酸进行混合并研磨,形成混合物五;
将制得的所述萃取液、所述混合物四和所述混合物五依次加入预先称取好的凡士林中,充分搅拌,形成糊状混合物;
将制得的糊状混合物进行加温,直至糊状混合物成为膏状的状态即得儿童过敏性鼻炎膏。
进一步的,所述混合物三萃取时,萃取压力为32-35MPa,萃取温度为40-45℃,二氧化碳流速为1-2L/min,萃取时间为先静态萃取30-60min,再动态萃取1.5-2h,分离压力为4.5-5.5MPa,分离温度为30-35℃。
进一步的,所述混合物一为400-600目,所述混合物二为300-400目,所述混合物三为100-150目。
进一步的,所述混合物四为100-150目。
进一步的,所述混合物五为100-150目。
进一步的,所述萃取液、所述混合物四和所述混合物加入所述凡士林中混合时采用超声波震荡20-25秒。
其中,本发明所采用的原料药份阐述如下:
辛夷花:又名木笔花为木兰科,落叶乔木植物,辛夷的花蕾,性温味辛、归肺、胃经,因它辛散温通、芳香走窜、上行头面、善通鼻窍、因治鼻渊头痛要药,同时只要适当配伍它偏寒偏热均可应用,药用价值颇高,内服外用都有较好的疗效。
苍耳子:属于一种祛风湿中药,主治发散风寒,通鼻窍,祛风湿,止痛。
路路通:为聚花果,由多数小蒴果集合而成,呈球形,功能主治祛风活络,利水通经,用于关节痹痛,麻木拘挛,水肿胀满,乳少经闭。
芙蓉叶:别名地芙蓉,为锦葵科木槿属植物。其根、叶、花均可入药,有凉血止血、清热解毒、活血消肿的功效。适合公园、庭院的绿化,也可盆栽观赏。
凡士林:是一种油脂状的石油产品,白色至黄棕色,有矿物油气味,而没有煤油气味,除去可作润滑剂、绝缘剂、化妆品、药用油膏、浸润和灌注电容外,当然可用于防锈、和防水剂。
艾叶:多年生草本或略成半灌木状,植株有浓烈香气,全草入药,有温经、去湿、散寒、止血、消炎、平喘、止咳、安胎、抗过敏等作用。
金银花:性甘寒气芳香,甘寒清热而不伤胃,芳香透达又可祛邪。金银花既能宣散风热,还善清解血毒,用于各种热性病,如身热、发疹、发斑、热毒疮痈、咽喉肿痛等症,均效果显著。
薄荷:薄荷是中华常用中药之一,是辛凉性发汗解热药,治流行性感冒、头疼、目赤、身热、咽喉、牙床肿痛等症,外用可治神经痛、皮肤瘙痒、皮疹和湿疹等,平常以薄荷代茶,清心明目。
甘草:别名甜根子,甘草属多年生草本,根与根状茎粗壮,是一种补益中草药,对人体很好的一种药,功能主治清热解毒、祛痰止咳、脘腹等。
猪牙皂:豆科皂荚属植物皂荚,因受外伤等影响而结出的畸形小荚果,祛痰开窍,散结消肿,用于中风口噤,昏迷不醒,癫痫痰盛,关窍不通,喉痹痰阻,顽痰喘咳,咯痰不爽,大便燥结,外治痈肿。
儿茶:是豆科金合欢属的植物,对病毒及某些真菌也有显著抑制作用。
露蜂房:为胡蜂科昆虫黄星长脚黄蜂或多种近缘昆虫的巢,对蛋清所致的足垫肿胀、棉球诱发的肉芽组织增生均有显着的抑制作用。
细辛:是一种被子植物门、双子叶植物纲、马兜铃目、马兜铃科、细辛族、细辛属类生物,多年生草本,根状茎直立或横走,可全草入药。
地榆:是蔷薇科地榆属多年生草本植物,纺锤形粗壮跟,短柄小叶,紫红色花瓣,果实包藏萼筒内,性寒,味苦酸,无毒,归肝、肺、肾和大肠经。有凉血止血,清热解毒,培清养阴,消肿敛疮等功效。
防风:别名铜芸、回云、回草、百枝、百种,防风的根可生用,味辛、甘,性微温,有祛风解表,胜湿止痛,止痉的功效。
白术:属多年生草本植物,结节状根状茎,药用功能运脾药,性味苦温辛烈,有燥湿、化浊、止痛之效。
青蒿素:是从植物黄花蒿茎叶中提取的有过氧基团的倍半萜内酯药物,主要用于间日疟、恶性疟的症状控制,以及耐氯喹虫株的治疗,也可用以治疗凶险型恶性疟,如脑型、黄疸型等,亦可用以治疗系统性红斑狼疮与盘状红斑狼疮。
败酱草:清热解毒,凉血,消痈排脓,祛瘀止痛。
肉苁蓉:补肾阳;益精血;润肠道。
牛蒡子:为菊科二年生草本植物牛蒡的干燥成熟果实,具有疏散风热,宣肺透疹,利咽散结,解毒消肿之功效,属于解表药中发散风热药,现代研究,牛蒡子还可用于防治糖尿病肾病,牛蒡果实含牛蒡甙经水解生成的牛蒡甙元具有抗癌活性。
黄芪:具有补气固表,利尿托毒,排脓,敛疮生肌的功效,用于气虚乏力,食少便溏,中气下陷,久泻脱肛,便血崩漏,表虚自汗,痈疽难溃,久溃不敛,血虚萎黄,内热消渴。
维生素E:是一种脂溶性维生素,其水解产物为生育酚,是最主要的抗氧化剂之一,维生素E可抑制眼睛晶状体内的过氧化脂反应,使末梢血管扩张,改善血液循环,预防近视眼发生和发展。
维生素C:又叫L-抗坏血酸,是一种水溶性维生素,水果和蔬菜中含量丰富,在氧化还原代谢反应中起调节作用,缺乏它可引起坏血病。
丝氨酸:是一种非必需氨基酸,它在脂肪和脂肪酸的新陈代谢及肌肉的生长中发挥着作用,因为它有助于免疫血球素和抗体的产生,维持健康的免疫系统也需要丝氨酸,丝氨酸在细胞膜的制造加工、肌肉组织和包围神经细胞的鞘的合成中都发挥着作用。
谷氨酸:是一种酸性氨基酸,分子内含两个羧基,化学名称为α-氨基戊二酸,谷氨酸在生物体内的蛋白质代谢过程中占重要地位,参与动物、植物和微生物中的许多重要化学反应。
L-组氨酸:用作营养强化剂,是氨基酸输液、复合氨基酸制剂中的重要组成,可用于治疗胃溃疡。
赖氨酸:是人体必需氨基酸之一,能促进人体发育、增强免疫功能,并有提高中枢神经组织功能的作用,赖氨酸为碱性必需氨基酸,由于谷物食品中的赖氨酸含量甚低,且在加工过程中易被破坏而缺乏,故称为第一限制性氨基酸。
盐酸左西替利嗪:主要用于缓解变态反应性疾病的过敏症状,临床上用于治疗变应性鼻炎、荨麻疹、血管神经性水肿等皮肤粘膜过敏性疾病,也用于减轻感冒时的过敏症状。
盐酸金刚烷胺:别名盐酸金刚胺、三环癸胺,可以抑制病毒穿入宿主细胞,并影响病毒的脱壳,抑制其繁殖,起治疗和预防病毒性感染作用。
磺胺甲基异恶唑:白色结晶性粉末,无臭,味微苦,难溶于水,易溶于稀盐酸、氢氧化钠溶液或氨试液中,抗菌谱广,抗菌作用强,对大多数革兰阳性及阴性菌均有抑菌作用,适用于呼吸系统、泌尿系统及肠道感染等,能阻碍细菌生长,对葡萄球菌及大肠杆菌作用特别强。
本发明的有益效果为:能够有效抑制细菌病毒生长、促进鼻腔组织修复、提高局部免疫状态,能够显著地改善过敏性鼻炎患者的临床症状和体征,且无明显毒副作用及不良反应的发生,利用中草药自身功效达到的培土固表、益气疏风、利窍通鼻之功效,用于脾肺气虚,外感风寒之鼻鼽病目的,能够有效治疗过敏性鼻炎,效果显著,副作用小,利于儿童的使用,具有明显的抗过敏和消炎作用,经临床实践证明,中药配方科学,诸药合用,效果明显,价格适中,使用方便,临床疗效显著。
附图说明
为了更清楚地说明本发明实施例或现有技术中的技术方案,下面将对实施例中所需要使用的附图作简单地介绍,显而易见地,下面描述中的附图仅仅是本发明的一些实施例,对于本领域普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据这些附图获得其他的附图。
图1是根据本发明实施例的一种儿童过敏性鼻炎膏的制备方法流程图。
具体实施方式
下面将结合本发明实施例中的附图,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员所获得的所有其他实施例,都属于本发明保护的范围。
根据本发明的实施例,提供了一种儿童过敏性鼻炎膏。
该儿童过敏性鼻炎膏由以下质量份数的原料制成:
辛夷花40-80份、苍耳子30-50份、路路通10-20份、芙蓉叶5-15份、凡士林20-40份、艾叶8-10份、金银花10-30份、薄荷2-4份、甘草3-8份、猪牙皂20-60份、儿茶4-12份、露蜂房10-30份、细辛15-45份、地榆1-3份、防风3-5份、白术1-3份、青蒿素0.1-1份、败酱草10-30份、肉苁蓉2-4份、牛蒡子1-5 份、黄芪15-25份、维生素组合物0.02-2份、氨基酸组合物0.4-4份和辅料0.3-3份。
其中,所述维生素组合物包括以下原料组份:维生素E为0.01-1份和维生素C为0.01-1份。
所述氨基酸组合物包括以下原料组份:丝氨酸为0.1-1份、谷氨酸为0.1-1份、L-组氨酸为0.1-1份和赖氨酸为0.1-1份。
所述辅料包括以下原料组份:盐酸左西替利嗪为0.1-1份、盐酸金刚烷胺为0.1-1份和磺胺甲基异恶唑为0.1-1份。
为了更清楚的理解本发明的上述技术方案,以下通过具体实例对本发明的上述方案进行详细说明。
实施例一
一种儿童过敏性鼻炎膏,该儿童过敏性鼻炎膏由以下质量份数的原料制成:
辛夷花40g、苍耳子30g、路路通10g、芙蓉叶5g、凡士林20g、艾叶8g、金银花10g、薄荷2g、甘草3g、猪牙皂20g、儿茶4g、露蜂房10g、细辛15g、地榆1g、防风3g、白术1g、青蒿素0.1g、败酱草10g、肉苁蓉2g、牛蒡子1g、黄芪15g、维生素组合物0.02g、氨基酸组合物0.4g和辅料0.3g。
其中,所述维生素组合物包括以下原料组份:维生素E为0.01g和维生素C为0.01g。
所述氨基酸组合物包括以下原料组份:丝氨酸为0.1g、谷氨酸为0.1g、L-组氨酸为0.1g和赖氨酸为0.1g。
所述辅料包括以下原料组份:盐酸左西替利嗪为0.1g、盐酸金刚烷胺为0.1g和磺胺甲基异恶唑为0.1g。
该儿童过敏性鼻炎膏的制备,包括以下步骤:
根据上述质量份数,称取所述儿童过敏性鼻炎膏所需各原料;
将称取好的辛夷花40g、苍耳子30g、路路通10g、芙蓉叶5g、艾叶8g、金银花10g、薄荷2g、甘草3g、猪牙皂20g、儿茶4g、露蜂房10g、细辛15g、地榆1g、防风3g、白术1g、青蒿素0.1g、败酱草10g、肉苁蓉2g、牛蒡子1g和黄芪15g依次进行清洗干净,晾干,将晾干后的后进行烘干、粉碎,并进行混合,形成混合物一;
通过预先设置的研磨机对所述混合物一进行研磨,促使所述混合物一的状态为粉状混合物二;
通过预先设置的金属分离器,对研磨后的混合物二进行筛选,形成混合物三;
将上述混合物三投入预先准备好的超临界二氧化碳流体萃取釜中进行萃取,制得萃取液;
将称取好的盐酸左西替利嗪为0.1g、盐酸金刚烷胺为0.1g和磺胺甲基异恶唑为0.1g进行混合并研磨,形成混合物四;
将称取好的维生素E为0.01g、维生素C为0.01g、丝氨酸为0.1g、谷氨酸为0.1g、L-组氨酸为0.1g和赖氨酸为0.1g进行混合并研磨,形成混合物五;
将制得的所述萃取液、所述混合物四和所述混合物五依次加入预先称取好的凡士林20g中,充分搅拌,形成糊状混合物;
将制得的糊状混合物进行加温,直至糊状混合物成为膏状的状态即得儿童过敏性鼻炎膏。
实施例二
一种儿童过敏性鼻炎膏,该儿童过敏性鼻炎膏由以下质量份数的原料制成:
辛夷花60g、苍耳子40g、路路通15g、芙蓉叶10g、凡士林30g、艾叶9g、金银花20g、薄荷30g、甘草5g、猪牙皂40g、儿茶7g、露蜂房20g、细辛30g、地榆2g、防风4g、白术2g、青蒿素0.5g、败酱草20g、肉苁蓉3g、牛蒡子3 g、黄芪20g、维生素组合物1g、氨基酸组合物2g和辅料1.5g。
其中,所述维生素组合物包括以下原料组份:维生素E为0.5g和维生素C为0.5g。
所述氨基酸组合物包括以下原料组份:丝氨酸为0.5g、谷氨酸为0.5g、L-组氨酸为0.5g和赖氨酸为0.5g。
所述辅料包括以下原料组份:盐酸左西替利嗪为0.5g、盐酸金刚烷胺为0.5g和磺胺甲基异恶唑为0.5g。
该儿童过敏性鼻炎膏的制备,包括以下步骤:
根据上述质量份数,称取所述儿童过敏性鼻炎膏所需各原料;
将称取好的辛夷花60g、苍耳子40g、路路通15g、芙蓉叶10g、艾叶9g、金银花20g、薄荷30g、甘草5g、猪牙皂40g、儿茶7g、露蜂房20g、细辛30g、地榆2g、防风4g、白术2g、青蒿素0.5g、败酱草20g、肉苁蓉3g、牛蒡子3 g和黄芪20g依次进行清洗干净,晾干,将晾干后的后进行烘干、粉碎,并进行混合,形成混合物一;
通过预先设置的研磨机对所述混合物一进行研磨,促使所述混合物一的状态为粉状混合物二;
通过预先设置的金属分离器,对研磨后的混合物二进行筛选,形成混合物三;
将上述混合物三投入预先准备好的超临界二氧化碳流体萃取釜中进行萃取,制得萃取液;
将称取好的盐酸左西替利嗪为0.5g、盐酸金刚烷胺为0.5g和磺胺甲基异恶唑为0.5g进行混合并研磨,形成混合物四;
将称取好的维生素E为0.5g、维生素C为0.5g、丝氨酸为0.5g、谷氨酸为0.5g、L-组氨酸为0.5g和赖氨酸为0.5g进行混合并研磨,形成混合物五;
将制得的所述萃取液、所述混合物四和所述混合物五依次加入预先称取好的凡士林30g中,充分搅拌,形成糊状混合物;
将制得的糊状混合物进行加温,直至糊状混合物成为膏状的状态即得儿童过敏性鼻炎膏。
实施例三
一种儿童过敏性鼻炎膏,该儿童过敏性鼻炎膏由以下质量份数的原料制成:
辛夷花80g、苍耳子50g、路路通20g、芙蓉叶15g、凡士林40g、艾叶10g、金银花30g、薄荷4g、甘草8g、猪牙皂60g、儿茶12g、露蜂房30g、细辛45g、地榆3g、防风5g、白术3g、青蒿素1g、败酱草30g、肉苁蓉4g、牛蒡子5 g、黄芪25g、维生素组合物2g、氨基酸组合物4g和辅料3g。
其中,所述维生素组合物包括以下原料组份:维生素E为1g和维生素C为1g。
所述氨基酸组合物包括以下原料组份:丝氨酸为1g、谷氨酸为1g、L-组氨酸为1g和赖氨酸为1g。
所述辅料包括以下原料组份:盐酸左西替利嗪为1g、盐酸金刚烷胺为1g和磺胺甲基异恶唑为1g。
该儿童过敏性鼻炎膏的制备,包括以下步骤:
根据上述质量份数,称取所述儿童过敏性鼻炎膏所需各原料;
将称取好的辛夷花80g、苍耳子50g、路路通20g、芙蓉叶15g、艾叶10g、金银花30g、薄荷4g、甘草8g、猪牙皂60g、儿茶12g、露蜂房30g、细辛45g、地榆3g、防风5g、白术3g、青蒿素1g、败酱草30g、肉苁蓉4g、牛蒡子5 g和黄芪25g依次进行清洗干净,晾干,将晾干后的后进行烘干、粉碎,并进行混合,形成混合物一;
通过预先设置的研磨机对所述混合物一进行研磨,促使所述混合物一的状态为粉状混合物二;
通过预先设置的金属分离器,对研磨后的混合物二进行筛选,形成混合物三;
将上述混合物三投入预先准备好的超临界二氧化碳流体萃取釜中进行萃取,制得萃取液;
将称取好的盐酸左西替利嗪为1g、盐酸金刚烷胺为1g和磺胺甲基异恶唑为1g进行混合并研磨,形成混合物四;
将称取好的维生素E为1g、维生素C为1g、丝氨酸为1g、谷氨酸为1g、L-组氨酸为1g和赖氨酸为1g进行混合并研磨,形成混合物五;
将制得的所述萃取液、所述混合物四和所述混合物五依次加入预先称取好的凡士林40g中,充分搅拌,形成糊状混合物;
将制得的糊状混合物进行加温,直至糊状混合物成为膏状的状态即得儿童过敏性鼻炎膏。
为了方便理解本发明的上述技术方案,以下结合附图对本发明的上述方案的流程进行详细说明,具体如下:
根据本发明的实施例,还提供了一种儿童过敏性鼻炎膏的制备方法。
如图1所示,在实际生产过程中,该儿童过敏性鼻炎膏的制备,包括以下步骤:
步骤S101,根据上述质量份数,称取所述儿童过敏性鼻炎膏所需各原料;
步骤S103,将称取好的辛夷花、苍耳子、路路通、芙蓉叶、艾叶、金银花、薄荷、甘草、猪牙皂、儿茶、露蜂房、细辛、地榆、防风、白术、青蒿素、败酱草、肉苁蓉、牛蒡子和黄芪依次进行清洗干净,晾干,将晾干后的后进行烘干、粉碎,并进行混合,形成混合物一;
步骤S105,通过预先设置的研磨机对所述混合物一进行研磨,促使所述混合物一的状态为粉状混合物二;
步骤S107,通过预先设置的金属分离器,对研磨后的混合物二进行筛选,形成混合物三;
步骤S109,将上述混合物三投入预先准备好的超临界二氧化碳流体萃取釜中进行萃取,制得萃取液;
步骤S111,将称取好的盐酸左西替利嗪、盐酸金刚烷胺和磺胺甲基异恶唑进行混合并研磨,形成混合物四;
步骤S113,将称取好的维生素E、维生素C、丝氨酸、谷氨酸、L-组氨酸、赖氨酸进行混合并研磨,形成混合物五;
步骤S115,将制得的所述萃取液、所述混合物四和所述混合物五依次加入预先称取好的凡士林中,充分搅拌,形成糊状混合物;
步骤S117,将制得的糊状混合物进行加温,直至糊状混合物成为膏状的状态即得儿童过敏性鼻炎膏。
在一个实施例中,所述混合物三萃取时,萃取压力为32-35MPa,萃取温度为40-45℃,二氧化碳流速为1-2L/min,萃取时间为先静态萃取30-60min,再动态萃取1.5-2h,分离压力为4.5-5.5MPa,分离温度为30-35℃。
在一个实施例中,所述混合物一为400-600目,所述混合物二为300-400目,所述混合物三为100-150目。
在一个实施例中,所述混合物四为100-150目。
在一个实施例中,所述混合物五为100-150目。
在一个实施例中,所述萃取液、所述混合物四和所述混合物加入所述凡士林中混合时采用超声波震荡20-25秒。
综上所述,借助于本发明的上述技术方案,能够有效抑制细菌病毒生长、促进鼻腔组织修复、提高局部免疫状态,能够显著地改善过敏性鼻炎患者的临床症状和体征,且无明显毒副作用及不良反应的发生,利用中草药自身功效达到的培土固表、益气疏风、利窍通鼻之功效,用于脾肺气虚,外感风寒之鼻鼽病目的,能够有效治疗过敏性鼻炎,效果显著,副作用小,利于儿童的使用,具有明显的抗过敏和消炎作用,经临床实践证明,中药配方科学,诸药合用,效果明显,价格适中,使用方便,临床疗效显著。
以上所述仅为本发明的较佳实施例而已,并不用以限制本发明,凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。
Claims (10)
1.一种儿童过敏性鼻炎膏,其特征在于,该儿童过敏性鼻炎膏由以下质量份数的原料制成:
辛夷花40-80份、苍耳子30-50份、路路通10-20份、芙蓉叶5-15份、凡士林20-40份、艾叶8-10份、金银花10-30份、薄荷2-4份、甘草3-8份、猪牙皂20-60份、儿茶4-12份、露蜂房10-30份、细辛15-45份、地榆1-3份、防风3-5份、白术1-3份、青蒿素0.1-1份、败酱草10-30份、肉苁蓉2-4份、牛蒡子1-5 份、黄芪15-25份、维生素组合物0.02-2份、氨基酸组合物0.4-4份和辅料0.3-3份。
2.根据权利要求1所述的儿童过敏性鼻炎膏,其特征在于,所述维生素组合物包括以下原料组份:维生素E为0.01-1份和维生素C为0.01-1份。
3.根据权利要求2所述的儿童过敏性鼻炎膏,其特征在于,所述氨基酸组合物包括以下原料组份:丝氨酸为0.1-1份、谷氨酸为0.1-1份、L-组氨酸为0.1-1份和赖氨酸为0.1-1份。
4.根据权利要求3所述的儿童过敏性鼻炎膏,其特征在于,所述辅料包括以下原料组份:盐酸左西替利嗪为0.1-1份、盐酸金刚烷胺为0.1-1份和磺胺甲基异恶唑为0.1-1份。
5.一种儿童过敏性鼻炎膏的制备方法,其特征在于,用于权利要求4所述的儿童过敏性鼻炎膏的制备,包括以下步骤:
根据上述质量份数,称取所述儿童过敏性鼻炎膏所需各原料;
将称取好的辛夷花、苍耳子、路路通、芙蓉叶、艾叶、金银花、薄荷、甘草、猪牙皂、儿茶、露蜂房、细辛、地榆、防风、白术、青蒿素、败酱草、肉苁蓉、牛蒡子和黄芪依次进行清洗干净,晾干,将晾干后的后进行烘干、粉碎,并进行混合,形成混合物一;
通过预先设置的研磨机对所述混合物一进行研磨,促使所述混合物一的状态为粉状混合物二;
通过预先设置的金属分离器,对研磨后的混合物二进行筛选,形成混合物三;
将上述混合物三投入预先准备好的超临界二氧化碳流体萃取釜中进行萃取,制得萃取液;
将称取好的盐酸左西替利嗪、盐酸金刚烷胺和磺胺甲基异恶唑进行混合并研磨,形成混合物四;
将称取好的维生素E、维生素C、丝氨酸、谷氨酸、L-组氨酸、赖氨酸进行混合并研磨,形成混合物五;
将制得的所述萃取液、所述混合物四和所述混合物五依次加入预先称取好的凡士林中,充分搅拌,形成糊状混合物;
将制得的糊状混合物进行加温,直至糊状混合物成为膏状的状态即得儿童过敏性鼻炎膏。
6.根据权利要求5所述的儿童过敏性鼻炎膏的制备方法,其特征在于,所述混合物三萃取时,萃取压力为32-35MPa,萃取温度为40-45℃,二氧化碳流速为1-2L/min,萃取时间为先静态萃取30-60min,再动态萃取1.5-2h,分离压力为4.5-5.5MPa,分离温度为30-35℃。
7.根据权利要求5所述的儿童过敏性鼻炎膏的制备方法,其特征在于,所述混合物一为400-600目,所述混合物二为300-400目,所述混合物三为100-150目。
8.根据权利要求5所述的儿童过敏性鼻炎膏的制备方法,其特征在于,所述混合物四为100-150目。
9.根据权利要求5所述的儿童过敏性鼻炎膏的制备方法,其特征在于,所述混合物五为100-150目。
10.根据权利要求5所述的儿童过敏性鼻炎膏的制备方法,其特征在于,所述萃取液、所述混合物四和所述混合物加入所述凡士林中混合时采用超声波震荡20-25秒。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810760818.1A CN108524682A (zh) | 2018-07-12 | 2018-07-12 | 一种儿童过敏性鼻炎膏及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810760818.1A CN108524682A (zh) | 2018-07-12 | 2018-07-12 | 一种儿童过敏性鼻炎膏及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108524682A true CN108524682A (zh) | 2018-09-14 |
Family
ID=63488198
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810760818.1A Withdrawn CN108524682A (zh) | 2018-07-12 | 2018-07-12 | 一种儿童过敏性鼻炎膏及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108524682A (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104398645A (zh) * | 2014-11-14 | 2015-03-11 | 李建军 | 一种治疗鼻炎、鼻窦炎的中药组合物 |
CN106511861A (zh) * | 2016-11-14 | 2017-03-22 | 南京汉尔斯生物科技有限公司 | 一种用于治疗过敏性鼻炎的中西药制剂及其制备方法 |
-
2018
- 2018-07-12 CN CN201810760818.1A patent/CN108524682A/zh not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104398645A (zh) * | 2014-11-14 | 2015-03-11 | 李建军 | 一种治疗鼻炎、鼻窦炎的中药组合物 |
CN106511861A (zh) * | 2016-11-14 | 2017-03-22 | 南京汉尔斯生物科技有限公司 | 一种用于治疗过敏性鼻炎的中西药制剂及其制备方法 |
Non-Patent Citations (1)
Title |
---|
徐沙沙等: "任勤教授治疗小儿变应性鼻炎经验", 《中国中医急症》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103656238A (zh) | 一种治疗风湿骨病的中药组合物 | |
CN101940703A (zh) | 一种具有治疗和调整保健作用的酊剂 | |
CN106994141B (zh) | 一种治疗便秘的中药组合物及其制备方法 | |
CN108653511A (zh) | 一种儿童过敏性鼻炎油及其制备方法 | |
CN104491068A (zh) | 一种治疗肝硬化的中药组合物 | |
CN104127702A (zh) | 一种治疗急性视神经炎的中药制剂及其制备方法 | |
CN103990103A (zh) | 用于局部麻醉的药物及其制备方法 | |
CN104352838A (zh) | 广东凉茶中药饮片组合制剂、制备方法及组合包装 | |
CN108524682A (zh) | 一种儿童过敏性鼻炎膏及其制备方法 | |
CN103041091B (zh) | 一种预防或治疗腹部外科手术后腹胀的药物组合物 | |
CN108743690A (zh) | 一种成人过敏性鼻炎油及其制备方法 | |
CN111419933A (zh) | 一种用于健脾开胃的中药组合物及其外用制剂和应用 | |
CN104306864A (zh) | 一种缓解麻醉后恶心呕吐的中药制剂及其制备方法 | |
CN104398797A (zh) | 治疗小儿脑积水的中药组合物及制备方法 | |
CN108542944A (zh) | 一种成人过敏性鼻炎膏及其制备方法 | |
CN104173771A (zh) | 治疗耳源性眩晕升清降浊的中药组合物及制备方法 | |
CN105688171B (zh) | 一种雏鸡用饲料添加剂及其制备方法 | |
CN103211988B (zh) | 治疗猪传染性胃肠炎症的药物组合 | |
CN103285116B (zh) | 一种用于治疗幼儿感冒的中药制剂 | |
CN108125237A (zh) | 一种镇咳祛痰抗炎的保健品及其制备工艺 | |
CN106620438A (zh) | 一种治疗小儿血管瘤的药物组合物 | |
CN104491652A (zh) | 一种用于治疗牛肺气肿的药物组合物及其制备方法 | |
CN105617321A (zh) | 一种用于治疗痰热咳嗽的汤剂药物及其制作方法 | |
CN105362993A (zh) | 治疗鹦鹉鱼白点病的酊剂及其制备方法 | |
CN105079392A (zh) | 治疗坐骨神经痛的制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20180914 |